Page History

This section illustrates how to use analysis standards to represent various aspects of the identification, descriptive characteristics, product design, and testing of tobacco products that occur separately from product testing in human subjects.  The concepts illustrated in the examples include:

Tobacco products can lead to chronic health effects that can take decades to manifest (e.g., lung cancer can take 20+ years), which would require long-term studies to assess. Population models and simulations provide a desirable alternative for making estimates and predictions of likely impact on morbidity/mortality at the population level in the absence of empirical data. Mathematical, computational, and simulation models can also help guide regulatory activities such as new product authorizations and policy development. Such models take into consideration both users and nonusers of tobacco products and include cohort models, agent-based models, deterministic and stochastic systemic dynamic models, and static and dynamic social network models. Examples in this section illustrate how analysis standards support assessment of the impact of tobacco products on populations of individuals.